E. Strauss and M. C. Dias-teixeira, Quality of life in hepatitis C, Liver Int. sept, vol.26, issue.7, pp.755-65, 2006.

E. R. Miller, S. Mcnally, J. Wallace, and M. Schlichthorst, The ongoing impacts of hepatitis c-a systematic narrative review of the literature, BMC Public Health, vol.12, p.22900973, 2012.

H. H. Thein, P. Maruff, M. D. Krahn, J. M. Kaldor, D. J. Koorey et al., Improved cognitive function as a consequence of hepatitis C virus treatment*, HIV Med, vol.8, issue.8, p.17944685, 2007.

M. Wright, R. Grieve, J. Roberts, J. Main, and H. C. Thomas, Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation

U. Siebert, G. Sroczynski, J. Wasem, W. Greiner, U. Ravens-sieberer et al., Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon ?-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany, Eur J Health Econ. juin, vol.6, issue.2, p.15902546, 2005.

S. Deuffic-burban, P. Deltenre, M. Buti, T. Stroffolini, J. Parkes et al., Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology, vol.143, p.22863764, 2012.

A. A. Dan, J. B. Kallman, R. Srivastava, Z. Younoszai, A. Kim et al., Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index, Liver Transpl. mars, vol.14, issue.3, p.18306356, 2008.

H. Thein, M. Krahn, J. M. Kaldor, and G. J. Dore, Estimation of utilities for chronic hepatitis C from SF-36 scores, Am J Gastroenterol. mars, vol.100, issue.3, p.15743364, 2005.

E. Khoury, A. C. Vietri, J. Prajapati, and G. , The burden of untreated hepatitis C virus infection: a US patients' perspective, Dig Dis Sci. nov, vol.57, issue.11, p.22674399, 2012.

J. Vietri, G. Prajapati, E. Khoury, and A. C. , The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries, BMC Gastroenterol, vol.13, p.23324473, 2013.

S. Pol, J. Chevalier, S. Branchoux, R. Perry, G. Milligan et al., P0747: Health related quality of life and utility values in chronic hepatitis C patients: A cross-sectional study in France, the Uk and Germany, J Hepatol. 1 avr, vol.62, p.606, 2015.

O. Dalgard, A. Egeland, K. Skaug, K. Vilimas, and T. Steen, Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection, Hepatology. janv, vol.39, issue.1, pp.74-80, 2004.

S. Zickmund, E. Y. Ho, M. Masuda, L. Ippolito, and D. R. Labrecque, « They treated me like a leper ». Stigmatization and the quality of life of patients with hepatitis C, PMID: 14521647 Quality of life in patients with chronic hepatitis C infection PLOS ONE, vol.18, pp.835-879, 2003.

C. Chong, A. Gulamhussein, E. J. Heathcote, L. Lilly, M. Sherman et al., Health-state utilities and quality of life in hepatitis C patients, Am J Gastroenterol. mars, vol.98, issue.3, p.12650799, 2003.

P. C. Hsu, M. Krajden, E. M. Yoshida, F. H. Anderson, G. A. Tomlinson et al., Does cirrhosis affect quality of life in hepatitis C virus-infected patients?, Liver Int. mars, vol.29, issue.3, p.19267865, 2009.

P. C. Hsu, C. A. Federico, M. Krajden, E. M. Yoshida, K. E. Bremner et al., Health utilities and psychometric quality of life in patients with early-and late-stage hepatitis C virus infection: Quality of life in HCV infection, J Gastroenterol Hepatol. janv, vol.27, issue.1, p.21679248, 2012.

M. Schwarzinger, S. Dewedar, C. Rekacewicz, A. Elaziz, K. M. Fontanet et al., Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt, Hepatol Baltim Md. dé c, vol.40, issue.6, pp.1434-1475, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00636181

A. J. Rodger, D. Jolley, S. C. Thompson, A. Lanigan, and N. Crofts, The impact of diagnosis of hepatitis C virus on quality of life, Hepatology, vol.30, issue.5, p.10534353, 1999.

D. M. Evon, K. M. Simpson, D. Esserman, A. Verma, S. Smith et al., Barriers to accessing care in patients with chronic hepatitis C: the impact of depression, Aliment Pharmacol Ther, vol.32, issue.9, p.21039678, 2010.

Z. Pavlovi?, D. Deli?, N. P. Mari?, O. Vukovi?, and M. Ja?ovi?-ga?i?, Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study, Psychiatr Danub. dé c, vol.23, issue.4, p.22075738, 2011.

R. Likert, A technique for the measurement of attitudes, Arch Psychol, vol.22, p.55, 1932.

J. A. Ewing, Detecting alcoholism. The CAGE questionnaire, JAMA, vol.12, issue.14, p.6471323, 1984.

J. Chevalier and G. Pouvourville, Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ. fé vr, vol.14, issue.1, p.21935715, 2013.

R. Brooks and E. Group, EuroQol: the current state of play. Health policy, vol.37, p.10158943, 1996.

L. Kleinman, M. Zodet, Z. Hakim, J. Aledort, C. Barker et al., Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C, Quality of Life Research, vol.9, issue.5, p.11190005, 2000.

K. B. Hussain, R. J. Fontana, C. A. Moyer, G. L. Su, N. Sneed-pee et al., Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C, Am J Gastroenterol. sept, vol.96, issue.9, p.11569704, 2001.

T. Kuwashiro, T. Mizuta, Y. Kawaguchi, S. Iwane, H. Takahashi et al., Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance, J Gastroenterol. 16 mars, vol.49, issue.2, p.23503838, 2013.

B. Afsar, R. Elsurer, S. Sezer, and N. F. Ozdemir, Quality of life in hemodialysis patients: hepatitis C virus infection makes sense, Int Urol Nephrol. déc, vol.41, issue.4, p.19430922, 2009.

E. Y. Chen, C. S. North, O. Fatunde, I. Bernstein, S. Salari et al., Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults, J Viral Hepat, vol.20, issue.10, p.24010645, 2013.

D. Dhumeaux, Prise en charge des personnes infectées par les virus de l'hépatite B ou de l'hé patite C: rapport de recommandations, 2014.

G. W. Torrance, Measurement of health state utilities for economic appraisal, J Health Econ. mars, vol.5, issue.1, pp.1-30, 1986.

R. Grieve, M. Grishchenko, and J. Cairns, SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility, Eur J Health Econ HEPAC Health Econ Prev Care. févr, vol.10, issue.1, pp.15-23, 2009.

J. Chevalier, Mesure de l'utilité attachée aux é tats de santé: valorisation de l'index d'utilité EQ-5D et é volution de l'é chelle actuelle en France. Measurement of health state utilities: Valuation of the EQ-5D and improvement of the descriptive system in the French context

D. Sur,